Temozolomide

TEMODAR

Alkylating Drug

NADAC/unit $1.9043

No Shortage 10 Manufacturers 58 ANDAs

Temozolomide damages cancer cell DNA to prevent tumor growth.

vs. brand TEMODAR: Generic saves up to 81% per unit

Covered Lives

Market Intelligence

2026-03-11 Class II Recall: Rising Pharma Holding, Inc.

Generic Manufacturers

ACCORD HEALTHCARE INCAMNEAL PHARMACEUTICALSCHARTWELL LIFE MOLECULES LLCCHEMI SPADEVA HOLDING ASEIRGEN PHARMA LTDHETERO LABS LTD UNIT VMERCK SHARP AND DOHME CORPRISING PHARMA HOLDINGS INCSUN PHARMACEUTICAL INDUSTRIES LTDZYDUS PHARMACEUTICALS USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Temozolomide drfinder.aiFind doctors who prescribe Temozolomide rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Temozolomide

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.